Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials Post author:Sam Post published:March 4, 2018 Post category:BioPharma Dermira plans to shutter the program and move on to more promising compounds. Source: BioSpace You Might Also Like ASLAN Release: Pharma To Present At The January 23, 2017 Achaogen Adds As Chief Business Officer September 17, 2017 Merck & Co. Opens Cambridge Exploratory Science Center, Plans to Hire 30 More Employees January 23, 2017
Merck & Co. Opens Cambridge Exploratory Science Center, Plans to Hire 30 More Employees January 23, 2017
